Introduction in laboratory tests. Drugs are predominant among these t · _ , factors, owing to their interference with analytical The development of a wide range of biological tests, ^^ a$ we]1 as their pharmacological effects; there mechanisation, and data processing have contributed to . § ^ extensive i itera ture on this problem (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) . the discovery of many factors that cause variations ---~~~^ , ^ ," * , * ^-Indeed, the interpretation of a laboratory result using l )Dr. zymatic methods may be difficult and even erroneous due to the following factors:
Analytical factors
Quality control is designed to detect most of these errors. The evolution towards more accurate and more specific techniques will make it possible to avoid, or at least control such errors.
Physiological or environmental factors
Variations due to age, sex, exercise, meal intake etc. are now well known, but the interference of environmental factors, such as climatic conditions, dietary habits, pesticides, and, of course, drugs, is also considerable and often more important.
With respect to environmental factors, it was considered necessary to initiate a systematic study of analytical interferences.
For this purpose a working sub-group "Drug Interference in Clinical Chemistry" (20) In this paper results relevant to points 2-5 above are presented. Ascorbic acid was selected in preference to acetyisalicylic acid as the first substance to be investigated by the above mentioned expert group. It was necessary to test a simple drug molecule that was easy to find commercially in a pure state, and that was known to interfere with certain tests used in clinical chemistry. Ascorbic acid fulfills these criteria and was chosen as a model for the general protocol.
Materials and Methods
For this study, commercially available ascorbic acid (no special lot) and commercial, lyoph ized human serum were chosen. An ascorbic acid overdose was simulated by mixing the control serum (redissolved in distilled water) and an "overloaded serum" (redissolved in an aqueous solution of ascorbic acid) (See Annexe "General protocol").
Data on the parameters studied, analytical methods, apparatus and technical equipment are given in table 1.
First study
The concentrations tested during the first study ranged from 0-2 g/1 of ascorbic acid. Methods listed in table 1 were studied. Measurements were performed in duplicate on each overloaded solution.
The sera were prepared daily, and the analyses were carried out on 5 consecutive days by routine methods within routine work at 8 laboratories of different members of the expert group in different countries of the European Communities. The results are presented in μηιοΐ/ΐ or in mmol/1 depending upon the parameter, accompanied by specifications of the equipment used, techniques and variation coefficient in the zone of values measured.
Since the parameters showed a more or less clear interference, additional statistical studies were carried out (table).
-Test of significance between control (dose 0) and the first ascorbic acid overdose (0.71 mmol/1) for each laboratory, for all laboratories together, regrouping laboratories according to the techniques used. -A 2-factor variance analysis was performed for each laboratory result. This made it possible to determine the significance of the difference between the control serum and the first serum (first concentration). Other analyses of variance were performed on the same parameters: one by regrouping all the laboratories, the other by regrouping laboratories using the same techniques (tab. 2).
Second study
This study was then extended in 4 laboratories, in order to identify the parameters that cause a distinct interference. Additional assays were performed at the following concentrations that are close to the therapeutic values: 0.14 mmol/1, 0.34 mmol/1, 0.71 mmol/l, 1.42 mmol/1. On the basis of this study with ascorbic acid, we have established a general protocol for the study of drug interference (cf. annexe).
The distribution of protocols and questionaires, samples of ascorbic acid and serum to each participant of the study, the collection and mathematical-statistical evaluation of experimental data and the preparation of results were performed under the supervision of the Chairman of the g'roup, Dr. Siest (14)· Discussion of results took place at the group's meetings at Geneva and Pont a Mousson.
Results
The evaluated "General protocol of analytical interference by ascorbic acid" is shown in the annexe.
First study
For certain parameters, no comment is called for, either because there is no interference, i.e.
Urea, Cholesterol, Calcium and Protein', or because the dispersion is too great and the variations are not systematic, i.e.
Bilirubin,AspartateAminotransferase', or because of the technical problems encountered, i.e.
Alkaline Phosphatase. For other parameters, a more or less clear interference is noted.
Glucose
Glucose oxidase methods yield results that are low (22) (23) (24) (25) , neocuproin methods yield results that are high with both methods (24, 26, 27) ; the variations are statistically significant.
Uric acid
Methods using uricase are not affected by ascorbic acid (28, 29) except when the second stage is based on copper reduction. Phosphotungstate techniques are affected significantly even at the lowest concentration of ascorbic acid (5, 23, 25, (30) (31) (32) .
Creatinine Three laboratories use methods without deproteinization. The interference is greater if measurement is preceded by dialysis. This might be due to a change in physical properties of the serum upon the addition of ascorbic acid (33) (34) (35) .
Inorganic Phosphate
The dispersion of results is great, the observed variations do not appear to be significant.
Second study
The results of this second study are demonstrated by four graphs.
Glucose (fig. 1)
Neocuproine methods show increasing, glucose oxidasePerid methods decreasing values with increasing concentrations of ascorbic acid; the effect is already apparent at therapeutical levels of ascorbic acid.
Methods using glucose oxidase without indicator reaction, hexokinaselglucQse-6'phosphate dehydrogenase or glucose dehydrogenase respectively > are not influenced by ascorbic acid.
Uric acid (fig. 2) Phosphotungstate methods show increasing values with increasing concentrations of ascorbic acid.
Uricase methods do riot behave in a uniform manner depending on the nature of the secondary reaction:
Uricase-hydrazone methods yield greatly decreased values, uricase neocuproin methods greatly increased values, being useless with higher concentrations of ascorbic acid.
The uncase/catalasejformaldehyde reaction (Kageyama)
is not affected (36) .
Creatinine ( fig. 3 ) Jaffe's reaction, used in mechanized analysis systems withput deproteinization, is influenced by ascorbic acid in different ways. Methods with dialysis show a primary decrease followed by an elevation up to normal values. Kinetic methods tend to elevated values with increasing amounts of ascorbic acid. All effects are more or less pronounced depending on the type of reagent or kit.
Inorganic phosphate (fig. 4 ) SnCly-hydrazine methods tend to lowered values with higher concentrations of ascorbic acid, but the difference is not significant.
Methods using hydroquinone-ascorbate, vanadate and p-methylaminophenoi are not influenced by ascorbic acid.
Discussion
The spread of results obtained by the 8 laboratories was considerable. As in all surveys, there is primarily a problem of accuracy. Each laboratory was not expected to change its calibration. In a special trial, a serum Autochemist having an "assigned" value was integrated into the series and the results adjusted using this value. The addition of the drug in vitro did not appear to increase the dispersion. Therefore, depending on the analytical systems, principles of the methods, combinations of reaction steps, reagents, kits, and instruments, it is not possible to discuss in a simple way the factors concerned in the interference by ascorbic acid. [
Methods that are not influenced by ascorbic acid are listed in table 3-These results agree with the existing literature. Table 4 shows those analytical methods for glucose, uric acid, and creatinine that are regarded as less recommendable. Concerning the risk of false interpretation of results, the concentrations and pharmacokinetic data for ascorbic acid in vivo cannot be neglected. The concentrations used in this study cover the zone of therapeutic values (0-0.125 g/1 = 0-0.71 mmol/1) and likewise values which may be attained due to therapeutic accidents (21) . To achieve more information it is necessary to perform studies in vitro as well as in vivo to link plasma concentrations of ascorbic acid to quantitative data of interferences in the analytical method. This aim overlaps with the field of "drug intep actions" and is regarded as part of clinical pharmacology.
Restricting our attention to the basic program, we have been able to reduce errors and misleading conclusions to a minimum by exclusion of interlaboratory, interdisciplinary, economic and political-specific and unspecific interests and influences.
The coupling of a method to one instrument by a manufacturer may force the responsible clinical chemist to use methods with a higher risk of drug interference: in such a case, method, kit or machine should be changed. Considering the consumption of ascorbic acid as vitamin tablets, juices, vegetables and fruits (including canned food with ascorbic acid as preservative), especially when there is a risk of infection the clinical chemist and 
Annexe
General protocol of analytical interference by ascorbic acid 6 specimens were analysed in duplicate on each of three days. 
